Amended Statement of Beneficial Ownership (sc 13d/a)
2022年9月22日 - 10:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED
IN STATEMENTS FILED PURSUANT
TO § 240.13d-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO
§ 240.13d-2(a)
(Amendment No. 3)1
Forte Biosciences, Inc.
(Name
of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
34962G109
(CUSIP Number)
Jacob Ma-Weaver
Cable Car Capital LLC
2261 Market Street #4307
San Francisco, California 94114
(415) 857-1965
Andrew Freedman, Esq.
Olshan Frome Wolosky LLP
1325 Avenue of the Americas
New York, New York 10019
(212) 451-2300
(Name, Address and Telephone Number of Person
Authorized to Receive Notices
and Communications)
September 15, 2022
(Date of Event Which Requires
Filing of This Statement)
If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule
13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box ¨.
Note: Schedules
filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See
§ 240.13d-7 for other parties to whom copies are to be sent.
1
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page.
The information required
on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
NAME OF REPORTING PERSON |
|
|
|
|
|
|
|
|
|
|
Funicular Funds, LP |
|
|
2 |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ |
|
|
|
|
(b) ☐ |
|
|
|
|
|
|
|
3 |
|
SEC USE ONLY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
SOURCE OF FUNDS |
|
|
|
|
|
|
|
|
|
|
WC |
|
|
5 |
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) |
☐ |
|
|
|
|
|
|
|
|
|
|
|
|
6 |
|
CITIZENSHIP OR PLACE OF ORGANIZATION |
|
|
|
|
|
|
|
|
|
|
Delaware |
|
NUMBER OF |
|
7 |
|
SOLE VOTING POWER |
|
SHARES |
|
|
|
|
|
BENEFICIALLY |
|
|
|
|
2,031,987 |
|
OWNED BY |
|
8 |
|
SHARED VOTING POWER |
|
EACH |
|
|
|
|
|
REPORTING |
|
|
|
|
0 |
|
PERSON WITH |
|
9 |
|
SOLE DISPOSITIVE POWER |
|
|
|
|
|
|
|
|
|
|
|
|
2,031,987 |
|
|
|
10 |
|
SHARED DISPOSITIVE POWER |
|
|
|
|
|
|
|
|
|
|
|
|
0 |
|
|
11 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
|
|
|
|
|
|
|
|
|
2,031,987 |
|
|
12 |
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |
☐ |
|
|
|
|
|
|
|
|
|
|
|
|
13 |
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) |
|
|
|
|
|
|
|
|
|
|
9.99% |
|
|
14 |
|
TYPE OF REPORTING PERSON |
|
|
|
|
|
|
|
|
|
|
PN |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
NAME OF REPORTING PERSON |
|
|
|
|
|
|
|
|
|
|
Jacob Ma-Weaver |
|
|
2 |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ |
|
|
|
|
(b) ☐ |
|
|
|
|
|
|
|
3 |
|
SEC USE ONLY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
SOURCE OF FUNDS |
|
|
|
|
|
|
|
|
|
|
OO |
|
|
5 |
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) |
☐ |
|
|
|
|
|
|
|
|
|
|
|
|
6 |
|
CITIZENSHIP OR PLACE OF ORGANIZATION |
|
|
|
|
|
|
|
|
|
|
USA |
|
NUMBER OF |
|
7 |
|
SOLE VOTING POWER |
|
SHARES |
|
|
|
|
|
BENEFICIALLY |
|
|
|
|
2,031,987 |
|
OWNED BY |
|
8 |
|
SHARED VOTING POWER |
|
EACH |
|
|
|
|
|
REPORTING |
|
|
|
|
0 |
|
PERSON WITH |
|
9 |
|
SOLE DISPOSITIVE POWER |
|
|
|
|
|
|
|
|
|
|
|
|
2,031,987 |
|
|
|
10 |
|
SHARED DISPOSITIVE POWER |
|
|
|
|
|
|
|
|
|
|
|
|
0 |
|
|
11 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
|
|
|
|
|
|
|
|
|
2,031,987 |
|
|
12 |
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |
☐ |
|
|
|
|
|
|
|
|
|
|
|
|
13 |
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) |
|
|
|
|
|
|
|
|
|
|
9.99% |
|
|
14 |
|
TYPE OF REPORTING PERSON |
|
|
|
|
|
|
|
|
|
|
IN |
|
The following
constitutes Amendment No. 3 to the Schedule 13D filed by the undersigned (“Amendment No. 3”). This Amendment No. 3 amends
the Schedule 13D as specifically set forth herein.
| Item 3. | Source and Amount of Funds or Other Considerations |
Item 3 is hereby amended and restated to read
as follows:
The Shares to which this Schedule 13D relates
were acquired for an aggregate purchase price of $2,592,739.82 inclusive of brokerage commissions. Funds for the purchase were obtained
from the available working capital of the Fund. Although the Fund has the ability to obtain margin loans in the ordinary course of its
business, no part of the purchase price was obtained on margin or through any other borrowings.
| Item 4. | Purpose of Transaction |
Item 4 is hereby amended to add the following:
The Reporting Persons purchased additional Shares
in order to partially offset the dilutive effect of the Issuer's misguided At-the-market offering (the “ATM”). The percentage
ownership in this filing is based on the number of Shares outstanding reported as of the Issuer’s most recent Quarterly Report filed
on Form 10-Q; however, given the ongoing nature of the offering, the Reporting Persons do not know the actual number of Shares currently
outstanding and the Reporting Persons’ percentage ownership may in fact be lower. The uncertainty surrounding the Issuer’s
ATM coupled with the Issuer’s equally misguided poison pill has restricted the Reporting Persons from making additional open market
purchases.
The Reporting Persons further note that the Issuer
has yet to respond to any of the concerns raised in the Reporting Persons’ August 24, 2022 letter to the Issuer’s Board, allowing
four weeks to pass without so much as an acknowledgment.
| Item 5. | Interest in Securities of the Issuer |
Items 5(a) – (c) are hereby amended and
restated to read as follows:
(a) The
aggregate percentage of Common Stock reported owned by the Reporting Persons is based on 20,340,265 shares outstanding as of August 12,
2022, which is the total number of shares outstanding as reported on the cover page of the Issuer’s Quarterly Report on Form 10-Q
filed with the Securities and Exchange Commission on August 15, 2022. As of the close of business on September 21, 2022, the Fund beneficially
owned 2,031,987 Shares. Cable Car, as the General Partner of the Fund, may be deemed the beneficial owner of the 2,031,987 Shares owned
by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed the beneficial owner of the 2,031,987 Shares owned by the
Fund.
(b) The
Fund has sole voting and dispositive power over the shares reported herein.
(c) The
transactions in the Shares by the Fund during the past sixty days are set forth in Schedule A and are incorporated herein by reference.
None of the Fund, Cable Car or Mr. Ma-Weaver have entered into any transactions in the Shares since the filing of the Schedule 13D. Each
Reporting Person and Cable Car disclaims beneficial ownership of such Shares except to the extent of his or its pecuniary interest therein.
Signature
After reasonable inquiry and to the best of
my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: September 22, 2022
|
Funicular Funds, LP |
|
|
|
By: |
/s/ Jacob Ma-Weaver |
|
|
Name: |
Jacob Ma-Weaver |
|
|
Title: |
Managing Member of the General Partner |
|
|
|
|
|
|
|
|
|
/s/ Jacob Ma-Weaver |
|
Jacob Ma-Weaver |
SCHEDULE A
TRANSACTIONS IN SECURITIES OF THE ISSUER
SINCE THE FILING OF AMENDMENT NO. 2 TO THE SCHEDULE 13D
Nature
of the Transaction |
Securities
Purchased/(Sold) |
Price
($) |
Date of
Purchase / Sale |
Purchase of Common Stock |
18,831 |
1.3092 |
08/25/2022 |
Purchase of Common Stock |
4,467 |
1.3050 |
08/26/2022 |
Purchase of Common Stock |
37,461 |
1.3050 |
08/29/2022 |
Purchase of Common Stock |
27,333 |
1.3050 |
08/30/2022 |
Purchase of Common Stock |
3,474 |
1.3050 |
08/31/2022 |
Purchase of Common Stock |
16,616 |
1.3050 |
09/01/2022 |
Purchase of Common Stock |
24,833 |
1.3047 |
09/02/2022 |
Purchase of Common Stock |
1,195 |
1.3075 |
09/06/2022 |
Purchase of Common Stock |
620 |
1.3061 |
09/07/2022 |
Purchase of Common Stock |
23,733 |
1.3144 |
09/08/2022 |
Purchase of Common Stock |
12,439 |
1.2847 |
09/09/2022 |
Purchase of Common Stock |
4,447 |
1.3050 |
09/12/2022 |
Purchase of Common Stock |
17,304 |
1.2742 |
09/13/2022 |
Purchase of Common Stock |
50,647 |
1.2890 |
09/15/2022 |
Purchase of Common Stock |
7,740 |
1.2450 |
09/16/2022 |
Purchase of Common Stock |
50,000 |
1.2616 |
09/16/2022 |
Purchase of Common Stock |
25,000 |
1.2258 |
09/19/2022 |
Purchase of Common Stock |
46,521 |
1.2350 |
09/20/2022 |
Purchase of Common Stock |
27,300 |
1.2348 |
09/21/2022 |
Tocagen (NASDAQ:TOCA)
過去 株価チャート
から 5 2024 まで 6 2024
Tocagen (NASDAQ:TOCA)
過去 株価チャート
から 6 2023 まで 6 2024